|
|
||||||
BiographyMr Marc Dunoyer was appointed Chairman of GSK Japan in January 2010 and in February 2010 to lead GSK's rare diseases business from R&D to commercialisation.... |
|||||||
| Date | Designation | Entity | Entity Description | Country |
|---|---|---|---|---|
| 2010 | GlaxoSmithKline PLC - United States | -- | United States | |
| 2013 | AstraZeneca PLC | Company In Pharmaceuticals, Biotechnology & Life Sciences | United Kingdom |